| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 03/26/2009 | WO2009038012A1 Heterocyclic compound |
| 03/26/2009 | WO2009037707A2 N-phenyl anthranilic acid derivatives and uses thereof |
| 03/26/2009 | WO2009037690A1 Adherent cells from adipose or placenta tissues and use thereof in therapy |
| 03/26/2009 | WO2009037357A1 Benzimidazole nf- kappab inhibitors |
| 03/26/2009 | WO2009037191A2 Use of g-csf for the treatment of stroke |
| 03/26/2009 | WO2009036590A1 Compounds isolated from antrodia cinnamomea and use thereof |
| 03/26/2009 | WO2009009768A3 METHODS OF INHIBITING THE FORMATION OF AMYLOID-β DIFFUSABLE LIGANDS USING A ACYLHYDRAZIDE COMPOUNDS |
| 03/26/2009 | WO2009007457A3 Compounds and methods for modulating rho gtpases |
| 03/26/2009 | WO2005044802A3 Tetrahydro-quinolinylurea derivatives as vrl antagonists |
| 03/26/2009 | US20090083863 p300 transgenic animal |
| 03/26/2009 | US20090082855 Coating for controlled release of a therapeutic agent |
| 03/26/2009 | US20090082459 Deuterium-enriched guanfacine |
| 03/26/2009 | US20090082458 Deuterium-enriched aliskiren |
| 03/26/2009 | US20090082454 Deuterium-enriched disufenton |
| 03/26/2009 | US20090082446 Use of Hydroxyoleic acid and related compounds in the manufacture of drugs |
| 03/26/2009 | US20090082426 Dimers of artemisinin derivatives, preparation thereof and therapeutic use thereof |
| 03/26/2009 | US20090082424 Small molecule antagonists of bcl-2 family proteins |
| 03/26/2009 | US20090082423 Soluble epoxide hydrolase inhibitors |
| 03/26/2009 | US20090082418 Deuterium-enriched fluvastatin |
| 03/26/2009 | US20090082410 Constitutively translocating cell line |
| 03/26/2009 | US20090082395 Soluble epoxide hydrolase inhibitors |
| 03/26/2009 | US20090082393 New addition salts of angiotensin-converting enzyme inhibitors with no donor acids, a process for their preparation and pharmaceutical compositions containing them |
| 03/26/2009 | US20090082390 Piperidine compounds for use as orexin receptor antagonist |
| 03/26/2009 | US20090082384 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders |
| 03/26/2009 | US20090082369 Pyrrolo[2,3d]pyrimidine compositions and their use |
| 03/26/2009 | US20090082349 Thiazolones for use as pi3 kinase inhibitors |
| 03/26/2009 | US20090082343 1,3-benzothiazinone derivatives and use thereof |
| 03/26/2009 | US20090082329 Novel Sulphur-Containing Cyclic Urea Derivatives, Preparation Thereof and Pharmaceutical Use Thereof as Kinase Inhibitors |
| 03/26/2009 | US20090082322 Gender Differences in Experimental Aortic Aneurysm Formation |
| 03/26/2009 | US20090082307 Culturing Lac Z-Y+ E. coli cell on glycerol and glucose in presence of lactose as exogenous precursor and isopropyl beta -D-thiogalactoside as inducer under conditions inducing the internalization according to a mechanism of active transport of exogenous precursor by cell and production of lactose |
| 03/26/2009 | US20090082292 inhibiting angiogenesis; corneal graft rejection; age related macular degeneration; diabetic retinopathy; dermatological disease |
| 03/26/2009 | US20090082285 Adiponectin expression promoter |
| 03/26/2009 | US20090082268 Muteins of Placental Growth Factor Type I, Preparation Method And Application Thereof |
| 03/26/2009 | US20090082267 Prevention and Reduction of Blood Loss |
| 03/26/2009 | US20090082265 Compositions and methods for treating diseases |
| 03/26/2009 | US20090081729 Compositions and Methods Comprising a Ligand of ChemerinR |
| 03/26/2009 | US20090081635 Modified heparinase iii and methods of sequencing therewith |
| 03/26/2009 | US20090081314 Glycemic Control, Diabetes Treatment, and Other Treatments with Acetyl Cholinesterase Inhibitors |
| 03/26/2009 | US20090081239 bind and neutralize Plasminogen Activator Inhibitor-1 (PAI-1) by converting PAI-1 to its latent form or increasing proteolytic cleavage; treating a fibrotic condition; inhibits accumulation of extracellular matrix (ECM) |
| 03/26/2009 | US20090081208 Optimized Fc variants and methods for their generation |
| 03/26/2009 | US20090081192 Methods of screening for compounds having anti-inflammatory activity |
| 03/26/2009 | US20090081182 Modified Lecithin-Cholesterol Acyltransferase Enzymes |
| 03/26/2009 | US20090081170 Cardiac progenitor cells |
| 03/26/2009 | US20090081123 Pharmaceutical compounds |
| 03/26/2009 | CA2699817A1 Benzimidazole nf- kappab inhibitors |
| 03/26/2009 | CA2699664A1 Adherent cells from adipose or placenta tissues and use thereof in therapy |
| 03/26/2009 | CA2699289A1 Thiazolidinedione analogues for the treatment of hypertension |
| 03/26/2009 | CA2698128A1 Use of g-csf for the treatment of stroke |
| 03/25/2009 | EP2039759A1 Ex-vivo expansion method under clinical grade conditions of haematopoietic stem cells isolated from bone marow to treat ischaemic diseases such as acute myocardial infartcion |
| 03/25/2009 | EP2039681A1 Cycloalkene derivatives, process for production of the derivatives, and use of the same |
| 03/25/2009 | EP2039361A2 Use of immunomodulatory compounds |
| 03/25/2009 | EP2039357A2 Combinations of sterol absorption inhibitor(s) with cardiovascular agent(s) for the treatment of vascular conditions |
| 03/25/2009 | EP2039354A1 Compound having activity of blocking nmda receptor channel, and pharmaceutical agent using the same |
| 03/25/2009 | EP2037950A2 Further medical uses of antisecretory protein |
| 03/25/2009 | EP2037928A2 Methods for treating atherosclerosis |
| 03/25/2009 | EP2037917A1 Pharmaceutical composition comprising amlodipine and losartan |
| 03/25/2009 | EP2037910A1 Use of cannabinoid receptor agonists as hypothermia inducing drugs for the treatment of ischemia |
| 03/25/2009 | EP2037893A2 Solid dosage forms of valsartan, amlodipine and hydrochlorothiazide and method of making the same |
| 03/25/2009 | EP2037740A2 Compositions and methods to enhance reverse cholesterol transport |
| 03/25/2009 | EP2000540A9 Triprenyl phenol compound, process for production of triprenyl phenol compound, and thrombolysis enhancer |
| 03/25/2009 | EP2000473A9 Trehalose compound and pharmaceutical comprising the compound |
| 03/25/2009 | EP2000152A9 Solid preparation having improved solubility |
| 03/25/2009 | EP1565206B1 Novel use of erythropoietin in heart diseases |
| 03/25/2009 | EP1472228B1 Process for the manufacture of hmg-coa reductase inhibitors |
| 03/25/2009 | EP1460999B1 Methods of making and using theaflavin, theaflavin-3-gallate, theaflavin-3'-gallate and theaflavin 3,3'-digallate and mixtures thereof |
| 03/25/2009 | EP1377579B1 Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents |
| 03/25/2009 | EP1353692B1 Methods and compositions for treatment of ocular neovascularization and neural injury |
| 03/25/2009 | EP1319183B1 Methods and products related to low molecular weight heparin |
| 03/25/2009 | EP1299421B1 Antibodies to human mcp-1 |
| 03/25/2009 | EP1287035B1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 03/25/2009 | CN101395152A Sigma receptor compounds |
| 03/25/2009 | CN101395136A New pyridin-3-amine derivatives |
| 03/25/2009 | CN101395135A New primary amines |
| 03/25/2009 | CN101394861A Extended release of neuregulin for improved cardiac function |
| 03/25/2009 | CN101394852A Heterocyclic aspartyl protease inhibitors, preparation and use thereof |
| 03/25/2009 | CN101392013A Ginsenoside Rb1 containing impurity ginsenoside Rh1 |
| 03/25/2009 | CN101392012A Partial and full agonists of A1 adenosine receptors |
| 03/25/2009 | CN101392002A Boronic acid salts and use thereof in the preparation of medicaments for treating thrombosis |
| 03/25/2009 | CN101392001A Carboxamides derivates, preparation method thereof and use on medicine |
| 03/25/2009 | CN101391105A Gene therapy for critical limb ischemia with wild type or mutant eNOS |
| 03/25/2009 | CN101391081A Medicine composition for treating qi and blood derangement of essential hypertension and preparation method thereof |
| 03/25/2009 | CN101391073A Da huoluo capsule preparation method |
| 03/25/2009 | CN101391053A Traditional Chinese medicine composition for treating hemorrhoid |
| 03/25/2009 | CN101391052A Traditional Chinese medicine composition for treating cerebral arteries emphraxis |
| 03/25/2009 | CN101391015A External traditional Chinese medicine powder for treating recurrent hemorrhoid |
| 03/25/2009 | CN101390999A External medicine for treating hemorrhoid |
| 03/25/2009 | CN101390986A Traditional Chinese medicine composition for cerebral thrombus and preparation method thereof |
| 03/25/2009 | CN101390976A Traditional Chinese medicine composing prescriptions for treating pulmonary heart disease |
| 03/25/2009 | CN101390887A Medicine composition of Panax notoginseng saponins |
| 03/25/2009 | CN101390873A Cytidine disodium triphosphate and arginine composition and preparation method thereof |
| 03/25/2009 | CN101390872A Use of ginsenoside Rb1 in preparing medicine for treating dilated cardiomyopathy |
| 03/25/2009 | CN101390871A Ginsenoside Rb1 containing impurity ginsenoside Rd |
| 03/25/2009 | CN101390870A Ginsenoside Rb1 containing impurity ginsenoside Rc |
| 03/25/2009 | CN101390856A Solid preparation of clopidogrel and preparation method thereof |
| 03/25/2009 | CN101390839A Policosanol drop pill and preparation method thereof |
| 03/25/2009 | CN101390551A Notoginseng flower ecchymosis removing instant tea |
| 03/25/2009 | CN101390550A Notoginseng flower ecchymosis removing bagged tea |
| 03/25/2009 | CN100471951C Method of diagnosing genotype of nucleic acid sample |
| 03/25/2009 | CN100471871C Therapeutic human anti-IL-1R1 monoclonal antibody |
| 03/25/2009 | CN100471842C Quinolone derivative or its salt |